What are ResMed's profit margins?

ResMed (RMD) runs a 61.6% gross margin and a 34.2% operating margin, with a 27.4% net margin.

Where do ResMed's ratios come from?

Every ratio is computed from ResMed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

ResMed RMD Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q3 '26	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Profitability
Gross margin	61.6%+0.7pp	60.9%+0.8pp	60.1%+0.7pp	59.4%+0.6pp	58.8%+0.4pp
Operating margin	34.2%+0.5pp	33.7%+0.5pp	33.2%+0.4pp	32.7%+0.6pp	32.1%+0.4pp
Net margin	27.4%-0.1pp	27.5%+0.2pp	27.4%+0.1pp	27.2%+1.1pp	26.2%+0.8pp
EBITDA margin	38.2%+0.7pp	37.5%+0.5pp	37%+0.4pp	36.6%+0.9pp	35.7%+0.4pp
Free cash flow margin	31.7%-1.5pp	33.2%-0.4pp	33.6%+1.3pp	32.3%+1.0pp	31.2%+3.0pp
Returns
Return on equity	25.2%-0.4pp	25.7%+0.3pp	25.4%-0.4pp	25.9%+0.1pp	25.8%+0.2pp
Return on assets	18.6%-0.4pp	19%+0.5pp	18.5%-0.1pp	18.6%+0.4pp	18.3%+0.5pp
Return on invested capital	26.5%+0.9pp	25.6%+0.5pp	25.1%-0.2pp	25.3%+1.0pp	24.3%+1.8pp
Efficiency
Asset turnover	0.7×0.0×	0.7×0.0×	0.7×0.0×	0.7×0.0×	0.7×0.0×
Inventory turnover	2.4×+0.1×	2.3×+0.1×	2.3×-0.1×	2.4×-0.1×	2.4×+0.2×
Liquidity
Current ratio	3×-0.1×	3.1×+0.2×	2.9×-0.6×	3.4×0.0×	3.4×+0.1×
Quick ratio	2.3×0.0×	2.3×+0.2×	2.1×-0.4×	2.5×0.0×	2.5×+0.2×
Cash ratio	1.2×+0.1×	1.1×0.0×	1.1×-0.1×	1.2×+0.2×	1×+0.4×
Leverage
Debt-to-equity	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.1×0.0×	0.2×0.0×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Net debt / EBITDA	-0.3×-0.1×	-0.2×0.0×	-0.1×0.0×	-0.2×-0.1×	-0×-0.2×
Interest coverage	54.4×-23.7×	78.1×-41.7×	119.8×-290×	409.7×—	——
Per Share
Book value per share	$44.55+3.2%	$43.18+3.6%	$41.67+2.9%	$40.50+7.5%	$37.67+5.8%
Valuation
Market capitalization	$32.7B-7.0%	$35.16B-12.3%	$40.08B+6.8%	$37.52B+14.1%	$32.88B-2.1%
Enterprise value	$32.14B-7.8%	$34.85B-12.4%	$39.8B+7.1%	$37.18B+13.4%	$32.79B-3.3%
Price / earnings	21.5×-2.1×	23.7×-4.2×	27.9×+1.1×	26.8×+1.8×	25×-1.9×
Price / sales	5.9×-0.6×	6.5×-1.1×	7.6×+0.3×	7.3×+0.7×	6.5×-0.3×
Price / book	5×-0.5×	5.6×-1.0×	6.5×+0.3×	6.3×+0.4×	5.9×-0.5×
EV / EBITDA	15.2×-2.0×	17.2×-3.2×	20.5×+0.7×	19.7×+1.4×	18.3×-1.2×
EV / sales	5.8×-0.7×	6.5×-1.1×	7.6×+0.3×	7.2×+0.7×	6.5×-0.3×
Free cash flow yield	5.4%+0.3pp	5.1%+0.7pp	4.4%0.0pp	4.4%-0.3pp	4.8%+0.6pp
Earnings yield	4.6%+0.4pp	4.2%+0.6pp	3.6%-0.1pp	3.7%-0.3pp	4%+0.3pp
Dividend yield	1%+0.1pp	0.9%+0.1pp	0.8%0.0pp	0.8%-0.1pp	0.9%0.0pp
PEG ratio	1.4×+0.1×	1.2×+0.3×	1×+0.2×	0.7×0.0×	0.7×0.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about ResMed.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are ResMed's profit margins?: ResMed (RMD) runs a 61.6% gross margin and a 34.2% operating margin, with a 27.4% net margin.
Where do ResMed's ratios come from?: Every ratio is computed from ResMed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.